加载中
NYSEHealthcareMedical - Healthcare Information Services
最新数据
US$10.81
+US$0.15 · +1.41%
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
前收盘价
US$10.81
+US$0.15 · +1.41%
盘中时间采用ET。市场数据可能有所延迟。
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
日内区间
当前US$10.81
52周区间
当前US$10.81
盘中时间采用ET。市场数据可能有所延迟。
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
日内区间
当前US$10.81
52周区间
当前US$10.81
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 4.81亿 USD | 4.2亿 USD | 3.56亿 USD | 2.81亿 USD | 2.13亿 USD |
| 销货成本 | 1.54亿 USD | 1.35亿 USD | 1.24亿 USD | 1.09亿 USD | 8138.8万 USD |
| 毛利 | 3.26亿 USD | 2.85亿 USD | 2.32亿 USD | 1.72亿 USD | 1.32亿 USD |
| 研究与开发 | 1.21亿 USD | 1.17亿 USD | 1.12亿 USD | 9124.4万 USD | 5226.5万 USD |
| 销售、一般及管理费用 | 1.8亿 USD | 1.98亿 USD | 2.27亿 USD | 2.32亿 USD | 1.75亿 USD |
| 营业费用 | 3.33亿 USD | 3.43亿 USD | 3.69亿 USD | 3.48亿 USD | 2.49亿 USD |
| 利息收入 | 217.3万 USD | 267.7万 USD | 406.5万 USD | 247.5万 USD | 7.9万 USD |
| 利息支出 | 695.3万 USD | 234.7万 USD | 185.4万 USD | 141.1万 USD | 116.3万 USD |
| 折旧和摊销 | 3145.3万 USD | 2788.6万 USD | 2948.7万 USD | 2530.4万 USD | 2451.7万 USD |
| 营业利润 | −661.2万 USD | −5809.7万 USD | −1.36亿 USD | −1.77亿 USD | −1.17亿 USD |
| 净利润 | 230.6万 USD | −5852.7万 USD | −1.37亿 USD | −1.76亿 USD | −1.18亿 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$12.00
上涨空间 11.01%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2242.78万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1439.64万0.02%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF823.29万0.01%954亿 USD0.05%US$235+0.80%
Fidelity Enhanced Small Cap ETFFESM548.29万0.08%64.1亿 USD0.28%US$45.46+0.46%
iShares Russell 2000 Growth ETFIWO423.76万0.03%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO348.66万0.02%180亿 USD0.06%US$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA278.95万0.01%218.24亿 USD0.03%US$32.79+0.40%
Principal U.S. Small-Cap Multi-Factor ETFPSC245.05万0.09%27亿 USD0.38%US$67.70+0.61%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAPrincipal U.S. Small-Cap Multi-Factor ETFPSCAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
